Kernal Biologics, Inc.
Kernal Bio is a venture-backed therapeutics company developing in vivo cell therapies using AI-designed mRNA and targeted lipid nanoparticle (tLNP) technology. The Senior Associate Scientist role supports the tLNP platform within a fast-paced biotech environment and offers opportunities for scientific growth and increased project ownership.
Headquarters
Cambridge, Massachusetts, United States
Company Size
11-50 employees
Founded
2016
Kernal Biologics is an onco-selective mRNA therapeutics company based in Cambridge, MA that develops in vivo cell therapies by programming cells directly inside the body through targeted delivery and selective translation. Their platform uses state-of-the-art AI models to ensure selective mRNA translation in target cells, enabling scalable in vivo CAR-T therapies for patients with cancer and auto-immune diseases. Kernal overcomes the manufacturing, cost, and accessibility limitations of current ex vivo cell therapies and has received up to $48 million in funding from ARPA-H to advance its pipeline.
Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies
Oct 3, 2025
Kernal Bio Awarded up to $48 Million from ARPA-H to Develop Lower Cost in vivo CAR T-cell Therapies for Hematological Cancers and Autoimmune Disease
Oct 7, 2025
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Jul 7, 2022
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kernal Biologics, Inc..
Kernal Biologics, Inc. didn’t post a salary, so this is our estimate from similar listings.
Kernal Biologics Enters Development Phase Reaching Critical
Jul 22, 2021
mRNA-LNP Process Development Scientist
Amino Collective
Senior Scientist I - II, Analytical R&D (Lipids SME)
AbbVie
Associate Scientist/Scientist I, LNP Formulations
Flagship Pioneering, Inc.
Scientist, Formulation Discovery
Eli Lilly and Company
Senior Research Associate – Targeted LNP Formulation (Non-Viral Delivery)
Bristol Myers Squibb
Senior Scientist, In vivo Immunology – Targeted LNP Delivery
Tr1X